In this commentary, the authors explain and call for a broader use of outcome-adaptive randomization when designing clinical trials to test multiple COVID-19 interventions. This design potentially reduces the number of deaths or other adverse outcomes incurred during a trial.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322770 | PMC |
| http://dx.doi.org/10.7326/M20-2933 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 interventions
8
multigroup adaptively
4
adaptively randomized
4
randomized trials
4
trials advantageous
4
advantageous comparing
4
comparing coronavirus
4
coronavirus disease
4
disease 2019
4
2019 covid-19
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!